Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

Annals of the Rheumatic Diseases

Volumn 63, Issue 3, 2004, Pages 297-301

  Fathi, M ^a   Dastmalchi, M ^a   Rasmussen, E ^a   Lundberg, I E ^a   Tornling, G ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; DERMATOMYOSITIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY; LUNG FUNCTION TEST; MALE; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SEROLOGY; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

ADULT; CHI-SQUARE DISTRIBUTION; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 1342322750     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.006122     Document Type: Article

References (30)

1. Wortmann RL. Inflammatory diseases of muscle. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Text book of rheumatology. 4th ed. Philadelphia: Saunders, 1993:1159-88.
2. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
3. Medsger TA, Robinson H, Masi AT. Factors affecting survivorship in polymyositis: a life-table study of 124 patients. Arthritis Rheum 1971;14:249-58.
4. Schwarz MI. The lung in polymyositis. Clin Chest Med 1998;19:701-12.
5. Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984;14:60-76.
6. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. Arthritis Rheum 1985;28:249-55.
7. Frazier AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974;65:403-7.
8. Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981;141:1005-10.
9. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
10. Marie I, Hatron P, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and dermatomyositis. J Rheumatol 1998;25:1336-43.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:403-7.
13. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
14. Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breath-holding technique for clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957;36:1-7.
15. Quanjer PH. Standardized lung function testing. Clin Respir Physiol 1983;19:1-95.
16. Koh ET, Seow A, Ong B, Ratnagopol P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 1993;52:857-61.
17. Oddis CV, Conte CG, Steen VD, Medsger TA. Incidence of polymyositis-dermatomyositis: a 20-years study of hospital diagnosed cases in Allegheny Country, PA 1963-1982. J Rheumatol 1990;17:1329-34.
18. Weitoft T. Occurrence of polymyositis in the country of Gavleborg, Sweden. Scand J Rheumatol 1997;26:104-6.
19. Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular disease. Eur Respir J 2001;18:69-80s.
20. Evans CC. Rheumatic and connective tissue diseases. Respir Med 2003:2029-42.
21. Gabby E, Tarala R, Will R, Carroll G, Adler B, Cameron D, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35.
22. Primack SL, Muller NL. Radiologic manifestations of the systemic autoimmune diseases. Clin Chest Med 1998;19:573-86.
23. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. Arthritis Rheum 1983;26:604-11.
24. Schumacher HR, Schimmer B, Gordon GV, Bookspan MA, Brogadir S, Dorwart BB. Articular manifestation of polymyositis and dermatomyositis. Am J Med 1979;67:287-92.
25. Miller FW. Myositis-specific autoantibodies; touchstones for understanding the inflammatory myopathies. JAMA 1993;270:1846-9.
26. Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J Rheumatol 1984;11:663-5.
27. Love AL, Leff RL, Fraser DD, Targoff IN, Dakalas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopothy: myositis-specific autoantibodies define useful homogeneous patients groups. Medicine (Baltimore) 1991;70:360-74.
28. Frank MB, McCubbin V, Trieu E, Wu Y, Isenberg DA, Targoff IN. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 1999;12:137-42.
29. Rutjes SA, Vree Ggberts WT, Jongen P, Van den Hoogen F, Pruun GJM, Van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopothic inflammatory myopathy. Clin Exp immunol 1997;109:32-40.
30. Venables PJW. Antibodies to Jo-1 and Ro-52: why do they go together? Clin Exp Immunol 1997;109:403-5.